Patents by Inventor David B. Teplow

David B. Teplow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8765147
    Abstract: The present disclosure relates to endophytic fungi from higher plants such as a Pteromischum sp. plant, and to extracts and compounds from such fungi that have desirable biological activities, such as antifungal and immunosuppressive activities. The present disclosure further relates to compositions comprising such extracts and compounds, as well as methods of making and using the compositions.
    Type: Grant
    Filed: November 14, 2011
    Date of Patent: July 1, 2014
    Assignee: The Regents of the University of California
    Inventors: Gary A. Strobel, Yuhao Ren, David B. Teplow
  • Publication number: 20130177596
    Abstract: The present disclosure relates to endophytic fungi from higher plants such as a Pteromischum sp. plant, and to extracts and compounds from such fungi that have desirable biological activities, such as antifungal and immunosuppressive activities. The present disclosure further relates to compositions comprising such extracts and compounds, as well as methods of making and using the compositions.
    Type: Application
    Filed: November 14, 2011
    Publication date: July 11, 2013
    Inventors: Gary A. Strobel, Yuhao Ren, David B. Teplow
  • Patent number: 8080256
    Abstract: The present disclosure relates to endophytic fungi from higher plants such as a Pteromischum sp. plant, and to extracts and compounds from such fungi that have desirable biological activities, such as antifungal and immunosuppressive activities. The present disclosure further relates to compositions comprising such extracts and compounds, as well as methods of making and using the compositions.
    Type: Grant
    Filed: November 6, 2008
    Date of Patent: December 20, 2011
    Assignee: Regents of the University of California
    Inventors: Gary A. Strobel, Yuhao Ren, David B. Teplow
  • Publication number: 20100266641
    Abstract: The present disclosure relates to endophytic fungi from higher plants such as a Pteromischum sp. plant, and to extracts and compounds from such fungi that have desirable biological activities, such as antifungal and immunosuppressive activities. The present disclosure further relates to compositions comprising such extracts and compounds, as well as methods of making and using the compositions.
    Type: Application
    Filed: November 6, 2008
    Publication date: October 21, 2010
    Inventors: Gary A. Strobel, Yuhao Ren, David B. Teplow
  • Patent number: 5981264
    Abstract: An isolated substantially pure pseudomonas culture, exemplified by pseudomonas syringae MSU 16H (ATCC No. 67028), produces the substantially pure peptide pseudomycin which has broad spectrum anti-fungal characteristics.
    Type: Grant
    Filed: January 27, 1998
    Date of Patent: November 9, 1999
    Assignee: The Research and Development Institute, Inc. at Montana State University
    Inventors: Gary A. Strobel, Leslie A. Harrison, David B. Teplow
  • Patent number: 5837685
    Abstract: Peptide antimycotics, termed pseudomycins, display broad spectrum antibiotic activity, and in particular are highly effective, non-toxic antibiotics against fungal pathogens of human and animal disease. The peptide antimycotics (pseudomycins) may be used in the treatment of the fungal pathogen Candida albicans. Also disclosed is a method of purification and isolation, including characterization, of the pseudomycins.
    Type: Grant
    Filed: June 27, 1996
    Date of Patent: November 17, 1998
    Assignee: Research and Development Institute Inc. at Montana State University
    Inventors: Gary A. Strobel, Leslie A. Harrison, David B. Teplow
  • Patent number: 5576298
    Abstract: Peptide antimycotics, termed pseudomycins, display broad spectrum antibiotic activity, and in particular are highly effective, non-toxic antibiotics against fungal pathogens of human and animal disease. The peptide antimycotics (pseudomycins) may be used in the treatment of the fungal pathogen Candida albicans. Also disclosed is a method of purification and isolation, including characterization, of the pseudomycins.
    Type: Grant
    Filed: September 15, 1994
    Date of Patent: November 19, 1996
    Assignee: Research and Development Institute, Inc. at Montana State University
    Inventors: Gary A. Strobel, Leslie A. Harrison, David B. Teplow